Overview

Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery

Status:
Completed

Trial end date:
2016-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare sitagliptin and placebo for the prevention of high blood glucose during surgery.

Phase:

Phase 4

Details

Lead Sponsor:

Emory University

Treatments:

Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Insulin, Long-Acting
Polystyrene sulfonic acid
Sitagliptin Phosphate